News
Zacks Investment Research on MSN5h
AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder CancerAstraZeneca AZN announced that the European Commission has approved its blockbuster cancer drug, Imfinzi (durvalumab), for a ...
Joseph Jacob, MD, discusses the promising impact of TAR-200.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback